These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6145430

  • 1. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
    Lindner E.
    Arzneimittelforschung; 1984; 34(3):270-6. PubMed ID: 6145430
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E, Murai T, Ishizaka Y, Sanai K.
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [Abstract] [Full Text] [Related]

  • 3. Hypotensive and antiarrhythmic effects of a new alkaloid, the 13-hydroxylupanine-2-pyrrolcarbonic acid ester, from the Madagascan plant Cadia ellisiana.
    Lindner E, Kaiser J, Schacht U.
    Arzneimittelforschung; 1976; 26(9):1651-7. PubMed ID: 11808
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW, Engelhardt G, Pelzer H.
    Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
    [Abstract] [Full Text] [Related]

  • 5. [Studies on the blood pressure of beta-adrenoceptor blocking drugs, particularly in relation to the mechanism of the pressor action induced by beta-adrenoceptor blocking drugs in rats (author's transl)].
    Maekawa H.
    Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):251-61. PubMed ID: 6124489
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y, Sato E, Miyagishi A, Aono S, Nakatani H.
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacology of 1-phenylaminoethylamino-3-(phenoxy)propanol derivatives with beta-adrenergic action].
    Femmer K, Heer S, Poppe H.
    Pharmazie; 1983 Jun; 38(6):409-14. PubMed ID: 6136994
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamic effects of a 2-piperazinotetralin (P-11)--combined alpha- and beta-adrenoceptor blocking drug with hypotensive action.
    Mutafova-Yambolieva V, Staneva-Stoytcheva D.
    Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):551-7. PubMed ID: 2906393
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. I: Bronchodilating effect.
    Murai T, Maejima T, Sanai K, Osada E.
    Arzneimittelforschung; 1984 Sep; 34(11A):1633-40. PubMed ID: 6152156
    [Abstract] [Full Text] [Related]

  • 10. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ, Hodgson WC, Sutherland SK.
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [Abstract] [Full Text] [Related]

  • 11. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M, Nakaya H, Hattori Y, Izumi T, Nishimura T, Sakai K, Abiko Y.
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamic profile of the selective beta 1-adrenoceptor antagonist bisoprolol.
    Harting J, Becker KH, Bergmann R, Bourgois R, Enenkel HJ, Fuchs A, Jonas R, Lettenbaur H, Minck KO, Schelling P.
    Arzneimittelforschung; 1986 Feb; 36(2):200-8. PubMed ID: 2870720
    [Abstract] [Full Text] [Related]

  • 13. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
    Schliep HJ, Harting J.
    J Cardiovasc Pharmacol; 1984 Feb; 6(6):1156-60. PubMed ID: 6084774
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol].
    Gries J, Unger L, Einig H, Friedrich L, Hofmann HP, Kreiskott H, Lehmann HD, von Philipsborn G, Wuppermann D, Zimmermann F.
    Arzneimittelforschung; 1988 Sep; 38(9):1271-9. PubMed ID: 2906243
    [Abstract] [Full Text] [Related]

  • 15. [Bepridil, a functional antagonist of beta1-adrenergic stimulation. Dissociated effects on cardiostimulation and lipolysis. (author's transl)].
    Constantin M, Beaughard M, Piris P, Labrid C.
    J Pharmacol; 1981 Sep; 12(3):239-54. PubMed ID: 6116833
    [Abstract] [Full Text] [Related]

  • 16. The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant.
    Strosberg AM.
    Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):200-15. PubMed ID: 10864
    [Abstract] [Full Text] [Related]

  • 17. Direct versus reflex activation of cardiac beta-adrenoceptors in the chronotropic and inotropic effects of isoprenaline and prenalterol in the conscious dog.
    Berdeaux A, Edouard A, Giudicelli JF.
    J Pharmacol; 1986 Aug; 17(3):266-74. PubMed ID: 2879069
    [Abstract] [Full Text] [Related]

  • 18. Aortic peak flow velocity as an index of myocardial contractility in the conscious rat.
    Dowell RT, Houdi AA.
    Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):533-9. PubMed ID: 9442476
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effects of metoprolol, practolol, and propranolol after isoprenaline injections in asthmatic patients (author's transl)].
    Svedmyr N, Thiringer G.
    Sem Hop; 1997 Oct; 56(15-16):798-804. PubMed ID: 6246620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.